Summit Therapeutics Limited
05197494
Some Concerns
No risk factors detected.
Details
Previously known as
Compliance
Last accounts
31/12/2024
full
Next accounts due
30/09/2026
Confirmation statement
Last: 19/09/2025
Due 03/10/2026
Industry
Officers
Former
corporate nominee director · Resigned 24/09/2004
corporate nominee director · Resigned 24/09/2004
corporate nominee secretary · Resigned 24/09/2004
secretary · Resigned 06/06/2005
director · Resigned 07/10/2005
director · Resigned 26/09/2006
director · Resigned 31/01/2008
director · Resigned 31/01/2008
director · Resigned 31/01/2008
secretary · Resigned 31/07/2008
director · Resigned 19/09/2008
secretary · Resigned 17/11/2008
director · Resigned 22/01/2009
secretary · Resigned 23/03/2009
director · Resigned 23/03/2009
secretary · Resigned 20/01/2010
director · Resigned 03/12/2010
director · Resigned 21/11/2012
director · Resigned 21/11/2012
director · Resigned 21/11/2012
director · Resigned 28/02/2013
secretary · Resigned 03/09/2014
director · Resigned 03/12/2014
director · Resigned 20/09/2018
director · Resigned 20/09/2018
director · Resigned 11/10/2019
director · Resigned 24/12/2019
director · Resigned 24/12/2019
director · Resigned 24/12/2019
director · Resigned 18/06/2020
director · Resigned 25/06/2020
secretary · Resigned 30/06/2020
director · Resigned 11/11/2020
director · Resigned 11/11/2020
director · Resigned 11/11/2020
director · Resigned 04/12/2020
secretary · Resigned 08/06/2021
director · Resigned 26/11/2021
director · Resigned 21/01/2022
director · Resigned 10/08/2022
director · Resigned 02/04/2024
Persons with Significant Control
Summit Therapeutics Inc.
Corporation Trust Center, 1209 Orange Street, Wilmington, 19801
Reg: 3262870 · Delaware Division Of Corporations · Corporation
Notified 18/09/2020
Charges0 outstanding
MNL PHARMA LIMITED
Change History
Active
Private Limited Company
136A EASTERN AVENUE
ABINGDON